Adagio Medical Holdings Income Statement (2023-2024) | ADGM

Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Revenue & cost
Revenue 0.04M0.08M0.03M0.25M0.13M
Cost of Revenue 0.25M0.33M0.54M0.68M0.41M
Gross Profit -0.21M-0.26M-0.52M-0.43M-0.28M
Operating items
Research & Development 4.42M1.77M3.47M2.87M1.22M
Selling, General & Administrative 4.45M3.30M4.83M3.37M2.93M
Other Operating Expenses -0.01M0.54M0.68M-0.01M
Operating Expenses 9.12M5.41M8.84M6.91M4.56M
Operating Income -9.08M-5.33M-8.81M-6.66M-4.42M
EBIT -9.08M-5.33M-8.81M-6.66M-4.42M
Non-operating items
Interest & Investment Income 0.00M0.00M0.00M0.00M0.17M
Other Non Operating Income -0.12M0.09M-0.04M0.01M0.07M
Non Operating Income -1.68M-3.29M0.80M0.93M8.03M
Net income details
EBT -9.56M-5.91M-9.57M-7.42M-4.69M
Profit After Tax -10.76M-8.63M-8.02M-5.73M3.61M
Income from Continuing Operations -9.56M-5.91M-9.57M-7.42M-4.69M
Consolidated Net Income -9.56M-5.91M-9.57M-7.42M-4.69M
Income towards Parent Company -9.56M-5.91M-9.57M-7.42M-4.69M
Net Income towards Common Stockholders -9.56M-5.91M-9.57M-7.42M-4.69M
Additional items
EPS (Basic) -14.15-11.33-10.28-7.350.18
EPS (Weighted Average and Diluted) -14.15-11.33-10.28-7.350.02
Shares Outstanding (Weighted Average) 1.00
Shares Outstanding (Diluted Average) 1.00
EBITDA -10.76M-8.63M-8.02M-5.73M3.60M
Interest Expenses 0.48M0.58M0.75M0.76M0.43M